Detalles de la búsqueda
1.
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Clin Infect Dis;
76(3): e188-e199, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35796536
2.
The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipients.
Am J Transplant;
23(9): 1411-1424, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37270109
3.
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International.
Nephrol Dial Transplant;
37(5): 825-839, 2022 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35134221
4.
Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
Gastroenterology;
157(2): 481-491.e7, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31022403
5.
Somatostatin in renal physiology and autosomal dominant polycystic kidney disease.
Nephrol Dial Transplant;
35(8): 1306-1316, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077332
6.
Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
Am J Nephrol;
50(5): 375-385, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31600749
7.
Renal functional reserve capacity before and after living kidney donation.
Am J Physiol Renal Physiol;
315(6): F1550-F1554, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30089036
8.
Vaccinated kidney transplant recipients are yet not sufficiently protected against COVID-19.
Nephrol Dial Transplant;
38(11): 2423-2425, 2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37370226
9.
Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease.
BMC Nephrol;
19(1): 368, 2018 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30567514
10.
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.
JAMA;
320(19): 2010-2019, 2018 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30422235
11.
Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients.
Clin Exp Nephrol;
21(3): 375-382, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27339446
12.
The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant.
Nephrol Dial Transplant;
36(9): 1761-1764, 2021 08 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34450647
13.
Estimation of total kidney volume in autosomal dominant polycystic kidney disease.
Am J Kidney Dis;
66(5): 792-801, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26235803
14.
Systemic oxidative stress may be associated with reduced IgG antibody titers against SARS-CoV-2 in vaccinated kidney transplant recipients: A post-hoc analysis of the RECOVAC-IR observational study.
Free Radic Biol Med;
215: 14-24, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38395091
15.
Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study.
Int J Infect Dis;
142: 106990, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38428480
16.
Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients.
Viruses;
16(1)2024 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38257814
17.
Blood pressure in early autosomal dominant polycystic kidney disease.
N Engl J Med;
372(10): 975, 2015 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25738677
18.
Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study.
EClinicalMedicine;
62: 102103, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533418
19.
Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy.
Clin Kidney J;
16(3): 528-540, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36865021
20.
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
Lancet Infect Dis;
23(3): 307-319, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36354032